Tsutsumi, Yutaka <br/><br/>
Efficacy and prognosis of antiviral therapy on hepatitis C following treatment of lymphoma in HCV-positive diffuse large-cell lymphoma.  [electronic resource] 

 -  Annals of hematology  Dec 2017 
 - 2057-2061 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>1432-0584 
<br/><br/><label>Standard No.: </label>10.1007/s00277-017-3129-0  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antibodies, Monoclonal, Murine-Derived--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Antiviral Agents--administration & dosage<br/>Cyclophosphamide--administration & dosage<br/>Disease-Free Survival<br/>Doxorubicin--administration & dosage<br/>Female<br/>Hepacivirus--metabolism<br/>Hepatitis C--blood<br/>Humans<br/>Lymphoma, Large B-Cell, Diffuse--blood<br/>Male<br/>Middle Aged<br/>Pilot Projects<br/>Prednisone--administration & dosage<br/>RNA, Viral--blood<br/>Rituximab<br/>Survival Rate<br/>Vincristine--administration & dosage